IL105100A0 - Glutamic acid derivatives and process for their preparation - Google Patents

Glutamic acid derivatives and process for their preparation

Info

Publication number
IL105100A0
IL105100A0 IL105100A IL10510093A IL105100A0 IL 105100 A0 IL105100 A0 IL 105100A0 IL 105100 A IL105100 A IL 105100A IL 10510093 A IL10510093 A IL 10510093A IL 105100 A0 IL105100 A0 IL 105100A0
Authority
IL
Israel
Prior art keywords
preparation
glutamic acid
acid derivatives
derivatives
glutamic
Prior art date
Application number
IL105100A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL105100A0 publication Critical patent/IL105100A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL105100A 1992-03-24 1993-03-18 Glutamic acid derivatives and process for their preparation IL105100A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/856,611 US5196424A (en) 1992-03-24 1992-03-24 N-[2-amino-4-substituted[[(pyrrollo or pyrido)[2,3-d]pyrimidinyl]-alkyl]benzoyl]-L-glutamic acids

Publications (1)

Publication Number Publication Date
IL105100A0 true IL105100A0 (en) 1993-12-28

Family

ID=25324069

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105100A IL105100A0 (en) 1992-03-24 1993-03-18 Glutamic acid derivatives and process for their preparation

Country Status (18)

Country Link
US (1) US5196424A (ru)
EP (1) EP0567223A1 (ru)
JP (1) JPH0625246A (ru)
KR (1) KR930019676A (ru)
CN (1) CN1078235A (ru)
AU (1) AU3542993A (ru)
BR (1) BR9301273A (ru)
CA (1) CA2091978A1 (ru)
CZ (1) CZ44093A3 (ru)
FI (1) FI931251A (ru)
HU (1) HUT70036A (ru)
IL (1) IL105100A0 (ru)
MX (1) MX9301544A (ru)
MY (1) MY131322A (ru)
NO (1) NO931008L (ru)
NZ (1) NZ247193A (ru)
TW (1) TW224098B (ru)
ZA (1) ZA931944B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457056A (en) * 1993-07-06 1995-10-10 Fiberchem, Inc. Halohydrocarbon sensing chemistry with base modifier
US6537999B2 (en) * 1996-06-06 2003-03-25 Duquesne University Of The Holy Ghost Pyrimidine derivatives and methods of making and using these derivatives
CA2263907A1 (en) * 1996-08-30 1998-03-05 Christopher Leighon Jordan Nonclassical pyrrolo[2,3-d]pyrimidine antifolates
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US8030319B2 (en) * 2005-02-10 2011-10-04 Duquesne University Of The Holy Ghost Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2 3-d]pyrimidines
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
CN1962658B (zh) * 2005-11-10 2010-05-12 北京大学 一种四氢吡啶并[3,2-d]嘧啶类化合物及制备抗肿瘤药物的用途
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
WO2011056957A2 (en) * 2009-11-06 2011-05-12 Chelsea Therapeutics, Inc. Enzyme inhibiting compounds
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102977107B (zh) * 2012-12-25 2015-04-22 山西普德药业股份有限公司 一种培美曲塞二钠化合物及其组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59170091A (ja) * 1983-03-17 1984-09-26 Takeda Chem Ind Ltd ６−チオ−７−デアザプリン誘導体およびその製造法
EP0119591B1 (en) * 1983-03-17 1988-06-22 Takeda Chemical Industries, Ltd. Thiodeazapurine derivatives
GB2160525B (en) * 1983-12-27 1987-08-26 Stanford Res Inst Int 8,10-dideazaminopterins
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
ZA861235B (en) * 1985-03-08 1986-10-29 Univ Princeton Pyrido(2,3-d)pyrimidine derivatives
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
US4988702A (en) * 1986-08-26 1991-01-29 Warner-Lambert Company Novel 9-deazaguanines
US4923872A (en) * 1986-08-26 1990-05-08 Warner-Lambert Co. Analogues of pyrrolo[3,2d]pyrimidin-4-ones
US4988813A (en) * 1986-10-20 1991-01-29 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
US4902796A (en) * 1986-10-20 1990-02-20 The Trustees Of Princeton University 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4921858A (en) * 1986-10-24 1990-05-01 Warner-Lambert Company 7-deazaguanines as immunomodulators
JP2830008B2 (ja) * 1988-04-01 1998-12-02 武田薬品工業株式会社 縮合ピリミジン誘導体
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
US4882333A (en) * 1988-05-25 1989-11-21 The Trustess Of Princeton University N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives
CH677140A5 (ru) * 1988-10-11 1991-04-15 W & E Umwelttechnik Ag
AU641183B2 (en) * 1989-09-19 1993-09-16 Teijin Limited Pyrrolo(2,3-d)pyrimidine derivative, process for preparing the same, and pharmaceutical preparation comprising the derivative as active ingredient
CA2032695A1 (en) * 1989-12-20 1991-06-21 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use

Also Published As

Publication number Publication date
CA2091978A1 (en) 1993-09-25
JPH0625246A (ja) 1994-02-01
FI931251A (fi) 1993-09-25
NO931008D0 (no) 1993-03-19
NZ247193A (en) 1995-05-26
NO931008L (no) 1993-09-27
HUT70036A (en) 1995-09-28
ZA931944B (en) 1994-09-18
US5196424A (en) 1993-03-23
CN1078235A (zh) 1993-11-10
FI931251A0 (fi) 1993-03-22
MY131322A (en) 2007-08-30
AU3542993A (en) 1993-09-30
HU9300804D0 (en) 1993-06-28
CZ44093A3 (en) 1994-02-16
MX9301544A (es) 1994-07-29
BR9301273A (pt) 1993-09-28
KR930019676A (ko) 1993-10-18
EP0567223A1 (en) 1993-10-27
TW224098B (ru) 1994-05-21

Similar Documents

Publication Publication Date Title
EP0449648A3 (en) Process for producing r(-)-mandelic acid and derivatives thereof
IL105100A0 (en) Glutamic acid derivatives and process for their preparation
HUP9603527A3 (en) 3-amino-2-mercaptobenzoic acid derivatives and processes for their and the intermediers preparation and the intermediers
CS316491A3 (en) Derivatives of amino acids, process of their preparation and pharmaceuticals based thereon
GB2240104B (en) New arylvinylamide derivatives and process for their preparation
AU3088489A (en) Phenoxyalkylcarboxylic acid derivatives and process for their preparation
AU649546B2 (en) Dicarboxylic acid derivatives and process for preparation thereof
ZA925871B (en) 3-deoxy-mannosamine derivatives and process for their preparation
GB9120628D0 (en) Pyrrolobenzoxazine derivatives and process for preparation thereof
EP0415510A3 (en) L-glutamic acid derivatives
AU1028892A (en) Phenoxyalkylcarboxylic acid derivatives and process of preparing the same
ZA933899B (en) Thienothiazine derivatives process for their preparation and their use
GB9204945D0 (en) 3-aryl-glycidic ester derivatives and process for their preparation
GB9409395D0 (en) Sialic acid derivatives and process for their preparation
IL102071A0 (en) Microbiological process for the preparation of 5-hydroxypyrazinoic acid
HU912979D0 (en) New amino acid derivatives and method for producing them
HU9300193D0 (en) Method for producing thio-carboxylic acid derivatives and their internmediate products
HU910563D0 (en) Process for producing 5-phenyl-1h-pyrazole-4-propionic acid derivatives and their pharmaceutical preparatives
EP0504069A3 (en) Process for preparing e-2-propyl-2-pentenoic acid and intermediate products
ZA9335B (en) Difluoromethylenandrostenone derivatives and process for their preparation
HU9502077D0 (en) Aryl-carboxilic acid derivatives and process for their preparation
LTIP499A (en) Microbiological process for preparing malonyl-7-aminocephalosporanic acid derivatives
EP0446925A3 (en) Process for the preparation of beta-resorcylic acid derivatives
GB9211646D0 (en) Sialic acid derivatives and process for their preparation
GB9224188D0 (en) Imidazolyalkyl-imidazolidinone derivatives and process for their preparation